A citation-based method for searching scientific literature

Vincenzo Ciocca, Alessandro Bombonati, Juan P Palazzo, Stephanie Schulz, Scott A Waldman. Histopathology 2009
Times Cited: 2







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CDX-2 immunostaining in primary and secondary ovarian carcinomas.
L Tornillo, H Moch, P-A Diener, A Lugli, G Singer. J Clin Pathol 2004
44
100

Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.
Russell Vang, Allen M Gown, Lee-Shu-Fune Wu, Todd S Barry, Darren T Wheeler, Anna Yemelyanova, Jeffrey D Seidman, Brigitte M Ronnett. Mod Pathol 2006
117
100


Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.
Viola A Heinzelmann-Schwarz, Richard A Scolyer, James P Scurry, Alison N Smith, Margaret Gardiner-Garden, Andrew V Biankin, Sally Baron-Hay, Carolyn Scott, Robyn L Ward, Daniel Fink,[...]. J Clin Pathol 2007
11
100

Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge.
Michael R Lewis, Michael T Deavers, Elvio G Silva, Anais Malpica. Am J Surg Pathol 2006
59
50


MUC2 is a molecular marker for pseudomyxoma peritonei.
Jerome T O'Connell, Cammy M Hacker, Sanford H Barsky. Mod Pathol 2002
58
50





Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct.
M Tascilar, G J Offerhaus, R Altink, P Argani, T A Sohn, C J Yeo, J L Cameron, M Goggins, R H Hruban, R E Wilentz. Am J Clin Pathol 2001
34
50

Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
Martin Köbel, Steve E Kalloger, David G Huntsman, Jennifer L Santos, Kenneth D Swenerton, Jeffrey D Seidman, C Blake Gilks. Int J Gynecol Pathol 2010
240
50


Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Andres G Chiesa, Michael T Deavers, Emanuela Veras, Elvio G Silva, David Gershenson, Anais Malpica. Int J Gynecol Pathol 2010
19
50


Mucinous tumors of the ovary: a review.
William R Hart. Int J Gynecol Pathol 2005
146
50

CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
Reda S Saad, Jan F Silverman, Mahmoud A Khalifa, Corwyn Rowsell. Appl Immunohistochem Mol Morphol 2009
30
50

Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
Brigitte M Ronnett, Anna V Yemelyanova, Russell Vang, C Blake Gilks, Dianne Miller, Patti E Gravitt, Robert J Kurman. Am J Surg Pathol 2008
95
50

No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
Nicolas Wentzensen, Andreas du Bois, Stefan Kommoss, Jacobus Pfisterer, Magnus von Knebel Doeberitz, Dietmar Schmidt, Friedrich Kommoss. Int J Gynecol Pathol 2008
18
50


p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
Oisin Houghton, Jackie Jamison, Robbie Wilson, James Carson, W Glenn McCluggage. Histopathology 2010
80
50


HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.
Jessica N McAlpine, Kimberly C Wiegand, Russell Vang, Bridgett M Ronnett, Anna Adamiak, Martin Köbel, Steve E Kalloger, Kenneth D Swenerton, David G Huntsman, C Blake Gilks,[...]. BMC Cancer 2009
122
50


p16 expression in the female genital tract and its value in diagnosis.
Ciaran J O'Neill, W Glenn McCluggage. Adv Anat Pathol 2006
172
50


p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Russell Vang, Allen M Gown, Maryam Farinola, Todd S Barry, Darren T Wheeler, Anna Yemelyanova, Jeffrey D Seidman, Kara Judson, Brigitte M Ronnett. Am J Surg Pathol 2007
59
50


A distinct molecular profile associated with mucinous epithelial ovarian cancer.
V A Heinzelmann-Schwarz, M Gardiner-Garden, S M Henshall, J P Scurry, R A Scolyer, A N Smith, A Bali, P Vanden Bergh, S Baron-Hay, C Scott,[...]. Br J Cancer 2006
75
50

Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.
Takako Okamoto, Noriomi Matsumura, Masaki Mandai, Tomonori Oura, Yukio Yamanishi, Akiko Horiuchi, Junzo Hamanishi, Tsukasa Baba, Masafumi Koshiyama, Tanri Shiozawa,[...]. Mod Pathol 2011
13
50



Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women.
B M Ronnett, B M Shmookler, M Diener-West, P H Sugarbaker, R J Kurman. Int J Gynecol Pathol 1997
148
50



Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases.
Ingrid M Rodriguez, Julie A Irving, Jaime Prat. Am J Surg Pathol 2004
54
50


Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival.
Martin C Chang, Nicole S Nevadunsky, Akila N Viswanathan, Christopher P Crum, Colleen M Feltmate. Int J Gynecol Pathol 2010
32
50


Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
W Glenn McCluggage, Robert H Young. Semin Diagn Pathol 2005
104
50


Massive abdominal and pelvic myxoma in Carney's syndrome.
W G McCluggage, M Y Walsh, C M Thornton, H R McClelland, S T Irwin. J Clin Pathol 2000
6
50


Cytokeratin 7 immunoreactivity in rectal adenocarcinomas.
Paul J Zhang, Mubina Shah, Gregory W Spiegel, John J Brooks. Appl Immunohistochem Mol Morphol 2003
34
50

Ovarian mucinous tumors frequently express markers of gastric, intestinal, and pancreatobiliary epithelial cells.
P Tenti, A Aguzzi, C Riva, L Usellini, R Zappatore, J Bara, I M Samloff, E Solcia. Cancer 1992
56
50

DPC4 gene in various tumor types.
M Schutte, R H Hruban, L Hedrick, K R Cho, G M Nadasdy, C L Weinstein, G S Bova, W B Isaacs, P Cairns, H Nawroz,[...]. Cancer Res 1996
620
50

Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
Ali Dastranj Tabrizi, Steve E Kalloger, Martin Köbel, Jane Cipollone, Calvin D Roskelley, Erika Mehl, C Blake Gilks. Int J Gynecol Pathol 2010
63
50

Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
P Argani, A Shaukat, M Kaushal, R E Wilentz, G H Su, T A Sohn, C J Yeo, J L Cameron, S E Kern, R H Hruban. Cancer 2001
84
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.